Written asthma action plans in emergency rooms
Tom Creer, PhD
September 1, 2010
Discussion (0) Digg This!

Ducharme FM et al. Written Action Plan in Pediatric Emergency Room Improves Asthma Prescribing, Adherence and Control. American Journal of Respiratory & Critical Care Medicine, August 27, 2010.

An acute-care visit for asthma often signals a management failure. While a written action plan is effective when combined with self-management education and regular medical review, its independent value remains controversial. Ducharme and colleagues examined the efficacy of providing a written action plan coupled with a prescription (WAP-P) to improve adherence to medications and other recommendations in a busy emergency department. They randomized 219 children aged 1-17 years to receive WAP-P (N=109) or unformatted prescription (UP) (N=110). All received fluticasone and albuterol inhalers, fitted with dose counters, to use at the discretion of the emergency physician. The main outcome was adherence to fluticasone (use/prescribed x100%) over 28 days. Secondary outcomes included pharmacy dispensation of oral corticosteroids, beta2-agonist use, medical follow-up, asthma education, acute-care visits, and control.
Though both groups showed a similar drop in adherence in the initial 14 days, adherence to fluticasone was significantly higher over days 15-28 in children receiving WAP-P [mean group difference: 16.13% (2.09, 29.91)]. More WAP-P than UP patients filled their oral corticosteroid prescription [Relative risk: 1.31 (1.07, 1.60)] and was well-controlled at 28 days [1.39 (1.04, 1.86)]. Compared to UP, use of WAP-P increased physicians prescription of maintenance fluticasone [2.47 (1.53, 3.99)] and recommendation for medical follow-up [1.87 (1.48, 2.35)], without group differences in other outcomes.

WHAT THE STUDY MAY MEAN TO YOU AS A HEALTH CARE PROVIDER: The authors concluded that provision of a written action plan significantly increased patient adherence to inhaled and oral corticosteroids and asthma control, as well as physicians' recommendation for maintenance fluticasone and medical follow-up that supports its independent value in the acute-care setting.

WHAT THE STUDY MAY MEAN TO YOU AS A HEALTH CARE CONSUMER: The results of an adherence study conducted over a 28 day period mean little. The study should have been conducted for at least 12 months to yield any meaningful data.

Save: Add to del.icio.us   Add to Technorati Favorites   Add to Yahoo! My Web   Add to Google Bookmarks     Printer Friendly Print

On This Site
More Articles
Syndication
Subscribe to this site's feed
Search the Site
Journal Articles
Self-management of asthma

A modest proposal: Universal self-management training for all

The Placebo Effect

Prevalence and Cost of Type 2 Diabetes Complications

Polypharmacy

Medication compliance or adherence

The importance of self-efficacy

Approaches to Health Care